Potential miRNA Involvement in the Anti-Adipogenic Effect of Resveratrol and Its Metabolites
dc.contributor.author | Eseberri Barace, Itziar | |
dc.contributor.author | Lasa Elguezua, Arrate | |
dc.contributor.author | Miranda Gómez, Jonatan | |
dc.contributor.author | Gracia Jadraque, Ana | |
dc.contributor.author | Portillo Baquedano, María Puy | |
dc.date.accessioned | 2019-05-08T07:56:58Z | |
dc.date.available | 2019-05-08T07:56:58Z | |
dc.date.issued | 2017-09-27 | |
dc.identifier.citation | Plos One 12(9) : (2017) // Article ID e0184875 | es_ES |
dc.identifier.issn | 1932-6203 | |
dc.identifier.uri | http://hdl.handle.net/10810/32685 | |
dc.description.abstract | Objective Scientific research is constantly striving to find molecules which are effective against excessive body fat and its associated complications. Taking into account the beneficial effects that resveratrol exerts on other pathologies through miRNA, the aim of the present work was to analyze the possible involvement of miRNAs in the regulation of adipogenic transcription factors peroxisome proliferator-activated receptor y (ppar gamma), CCAAT enhancer-binding proteins a and beta (cebp beta and cebpa) induced by resveratrol and its metabolites. Methods 3T3-L1 maturing pre-adipocytes were treated during differentiation with 25 mu M of trans-resveratrol (RSV), trans-resveratrol-3-O-sulfate (3S), trans-resveratrol-3'-O-glucuronide (3G) and trans-resveratrol-4'-O-glucuronide (4G). After computational prediction and bibliographic search of miRNAs targeting ppar gamma, cebp beta and cebpa, the expression of microRNA-130b-3p (miR-130b-3p), microRNA-155-5p (miR-155-5p), microRNA-27b-3p (miR-27b-3p), microRNA-31-5p (miR-31-5p), microRNA-326-3p (miR-326-3p), microRNA-27a-3p (miR27a-3p), microRNA-144-3p (miR-144-3p), microRNA-205-5p (miR-205-5p) and microRNA224-3p (miR-224-3p) was analyzed. Moreover, other adipogenic mediators such as sterol regulatory element binding transcription factor 1 (srebfl), kriippel-like factor 5 (k1f5), liver x receptor a (lxra) and cAMP responding element binding protein 1 (crebl), were measured by Real Time RT-PCR. As a confirmatory assay, cells treated with RSV were transfected with anti-miR-155 in order to measure cebp beta gene and protein expressions. Results Of the miRNAs analyzed only miR-155 was modified after resveratrol and glucuronide metabolite treatment. In transfected cells with anti-miR-155, RSV did not reduce cebp beta gene and protein expression. 3S decreased gene expression of crebl, klf5, srebfl and lxra. Conclusions While RSV and glucuronide metabolites exert their inhibitory effect on adipogenesis through miR-155 up-regulation, the anti-adipogenic effect of 3S is not mediated via miRNAs. | es_ES |
dc.description.sponsorship | This study was supported by grants from the Ministerio de Economia y Competitividad (AGL2011-27406-ALI), Institute de Salud Carlos III (CIBERObn), Government of the Basque Country (IT-572-13) and University of the Basque Country (UPV/EHU) (ELDUNANOTEK UFI11/32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. I. Eseberri is a recipient of a doctoral fellowship from the University of the Basque Country. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Public Library Science | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.subject | 3T3-L1 preadipocyte differentiation | es_ES |
dc.subject | activated-receptor-gamma | es_ES |
dc.subject | adipocyte differentiation | es_ES |
dc.subject | PPAR-gamma | es_ES |
dc.subject | inhibits adipogenesis | es_ES |
dc.subject | transcriptional control | es_ES |
dc.subject | regulated expression | es_ES |
dc.subject | adipose-tissue | es_ES |
dc.subject | micrornas | es_ES |
dc.subject | gene | es_ES |
dc.title | Potential miRNA Involvement in the Anti-Adipogenic Effect of Resveratrol and Its Metabolites | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.holder | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Attribution 4.0 International (CC BY 4.0) | es_ES |
dc.rights.holder | Atribución 3.0 España | * |
dc.relation.publisherversion | https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0184875 | es_ES |
dc.identifier.doi | 10.1371/journal.pone.0184875 | |
dc.departamentoes | Farmacia y ciencias de los alimentos | es_ES |
dc.departamentoeu | Farmazia eta elikagaien zientziak | es_ES |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Attribution 4.0 International (CC BY 4.0)